Professor Achillefs Kapanidis Awarded IOI Synergy Grant
Professor Achillefs Kapanidis Awarded IOI Synergy Grant
Kavli Oxford’s Professor Achillefs Kapanidis, co-Deputy Director of the Kavli Institute for Nanoscience Discovery and Professor of Biological Physics at the Department of Physics, has been awarded an IOI Synergy Grant to further his research on antimicrobial resistance (AMR).
E.coli bacterial cells classified as antibiotic-sensitive (blue) and antibiotic-resistant (red) by a deep-learning network.
The Ineos Oxford Institute for Antimicrobial Research (IOI) has awarded funds to six successful projects across the University of Oxford, all focused on developing new solutions with translational potential to combat the growing threat of AMR.
Professor Kapanidis' project will focus on creating a microfluidics-enabled imaging platform to rapidly identify bacterial pathogens and determine their antibiotic resistance profiles. Collaborating with colleagues from the Nuffield Department of Medicine and the Nuffield Department of Women's and Reproductive Health, this research aims to provide fast and accurate diagnostic tools that can help clinicians make timely treatment decisions.
The IOI Synergy Grant programme supports multidisciplinary collaboration spanning 11 departments across the university, funding research that has the potential for real-world impact in the fight against AMR. Professor Kapanidis' project is one of six selected from a competitive pool of submissions following an international peer-review process.
This initiative highlights the diversity of AMR research at Oxford, with projects ranging from antibiotic discovery to behavioural interventions, ensuring that the university remains at the forefront of tackling this critical global health issue.
We are delighted to see strong IOI support for our work on the rapid detection of AMR, a tight multi-disciplinary collaboration with Nicole Stoesser (Nuffield Department of Medicine) and Christoffer Nellåker (Big Data Institute). AMR continues to be a huge global problem, and we hope that our efforts will contribute to better bacterial diagnostics that will in turn help rationalise the use of antibiotics and preserve this precious resource. - Professor Achillefs Kapanidis
Since April 2021, Oxford University's KAVLI Institute for Nanoscience Discovery is proudly serving as a hub for research groups from seven different departments spanning both the medical and physical sciences, including Professor Achillefs Kapanidis's group from the Department of Physics.
